Home
Conditions
Mantle Cell Lymphoma

Clinical trial condition

Mantle Cell Lymphoma

Explore clinical trials studying Mantle Cell Lymphoma. Study availability and eligibility vary by location and protocol.

252 public trials 59 recruiting studies

Refine in advanced search Browse all conditions

Mantle Cell Lymphoma trial results

Not yet recruiting

Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy

NCT07711327

Conditions: Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Fibrillation (AF), +35 more
Locations: City of Hope Duarte, California, United States

UC San Diego Health San Diego, California, United States

Stanford Health Care Stanford, California, United States

View Trial Details

Not yet recruiting

HDM2005 Combination Therapy in Relapsed/Refractory Mantle Cell Lymphoma

NCT07697339

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Connected Blood Pressure Monitoring in Patients With Hematologic Malignancies Initiating Covalent BTK Inhibitors

NCT07592481

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +34 more
Locations: Not specified

View Trial Details

Not yet recruiting

PirtobrUtinib as Frontline Therapy for Elderly Unfit/Frail Patient With MAntle Cell Lymphoma

NCT07207785

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: IRCCS Istituto Romagnolo per lo studio dei Tumori "Dino Amadori" - IRST S.R.L. - Ematologia Meldola, Forlì-Cesena, Italy

Istituto Clinico Humanitas - U.O. Ematologia Rozzano, Milano, Italy

AOU Ospedali Riuniti - Clinica di Ematologia Ancona, Italy

Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico Avellino, Italy

View all 20 locations

View Trial Details

Not yet recruiting

Chemotherapy Combined With Targeted Therapy as First-line Treatment for Mantle Cell Lymphoma Based on MRD and PET-CT Assessment

NCT07206264

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Fujian Provincial Cancer Hospital Fuzhou, Fujian, China

Hebei Medical University Tumor Hospital Shijiazhuang, Hebei, China

Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China

Shandong Cancer Hospital Jinan, Shandong, China

View Trial Details

Not yet recruiting

A Prospective, Single-Center Study Evaluating the Efficacy and Safety of Glofitamab Combined With Orelabrutinib and Bortezomib in Patients With High-Risk Mantle Cell Lymphoma

NCT06656221

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Linperlisib Plus Obinutuzumab and Venetoclax for Relapsed and Refractory Blastoid Variant of Mantle Cell Lymphoma.

NCT06324994

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: The Second Hospital Dalian Medical University Dalian, Liaoning, China

View Trial Details

Not yet recruiting

A Single-arm, Single-center, Open-label Phase II Study of Zanubrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle CellLymphoma Patients

NCT06255704

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Hematology Department of ShanXi Cancer Hospital Taiyuan, Shanxi, China

View Trial Details

Not yet recruiting

Patient Perspectives in Mantle Cell Lymphoma Clinical Research

NCT06049472

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Power Life Sciences San Francisco, California, United States

View Trial Details

Enrolling by invitation

CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas

NCT07168486

Conditions: B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +31 more
Locations: University of Maryland, Baltimore Baltimore, Maryland, United States

View Trial Details

Mantle Cell Lymphoma

Mantle Cell Lymphoma trial results

Related conditions